Enhabit, Inc. (NYSE: EHAB) is a leading provider of home health and hospice services in the United States. The company is known for its comprehensive care solutions, catering to patients in need of medical assistance at home. Enhabit competes with other healthcare service providers in the industry, striving to deliver quality care and maintain a strong market presence.
On February 23, 2026, UBS downgraded EHAB's stock grade to Neutral from its previous Hold rating. At the time of this announcement, the stock was priced at $13.60. This downgrade comes amidst significant developments for Enhabit, as the company has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC. The acquisition is valued at approximately $1.1 billion in an all-cash transaction.
Enhabit stockholders are set to receive $13.80 per share in cash as part of the acquisition agreement. This offer includes a premium over the current stock price of $13.60. The stock has seen a notable increase of 22.63%, equivalent to a rise of $2.51, reflecting investor optimism about the acquisition. The stock's price has fluctuated between $13.55 and $13.64 today, with $13.64 marking its highest price over the past year.
EHAB's market capitalization is approximately $689.4 million, with a trading volume of 12.6 million shares. Over the past year, the stock's lowest price was $6.47, indicating a significant recovery and growth in value. The acquisition by Kinderhook Industries is a strategic move that could further enhance Enhabit's market position and benefit its stakeholders.
